Behavioral Neurobiology of Psychedelic Drugs
Editors: Halberstadt, Adam, Vollenweider, Franz X., Nichols, David E. (Eds.)
- The volume brings together clinical and preclinical research literatures
- A balanced view of the potential risks and benefits of these compounds is presented
- The focus is on rigorous scientific findings in a field that has been fraught with speculative reports
Buy this book
- About this book
-
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
Buy this book
Services for this Book
Recommended for you
Bibliographic Information
- Bibliographic Information
-
- Book Title
- Behavioral Neurobiology of Psychedelic Drugs
- Editors
-
- Adam Halberstadt
- Franz X. Vollenweider
- David E. Nichols
- Series Title
- Current Topics in Behavioral Neurosciences
- Series Volume
- 36
- Copyright
- 2018
- Publisher
- Springer-Verlag Berlin Heidelberg
- Copyright Holder
- Springer-Verlag GmbH Germany, part of Springer Nature
- eBook ISBN
- 978-3-662-55880-5
- DOI
- 10.1007/978-3-662-55880-5
- Hardcover ISBN
- 978-3-662-55878-2
- Series ISSN
- 1866-3370
- Edition Number
- 1
- Number of Pages
- X, 430
- Number of Illustrations and Tables
- 38 b/w illustrations, 158 illustrations in colour
- Topics
